| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 03/05/2008 | CN101137654A Novel salt of quinuclidine derivative |
| 03/05/2008 | CN101137650A 2-[(isoquinolin-3-carbonyl)amino]-propionic acid derivatives as inhibitors of factors xi and ix for the treatment of thrombosis |
| 03/05/2008 | CN101137643A Novel pyridine compounds |
| 03/05/2008 | CN101137413A 组合物和装置 Combinations thereof, and means |
| 03/05/2008 | CN101137412A Substituted biaryl compounds as factor xia inhibitors |
| 03/05/2008 | CN101137396A Production of bioactive glycoproteins from inactive starting material |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/05/2008 | CN101134107A Antithrombotic agents |
| 03/05/2008 | CN101134049A Donkey-hide gelatin powder for strengthening immunity and/or improving anaemia |
| 03/05/2008 | CN101134029A Use of alvianolic acid B salt as Na+/K+-ATP enzyme inhibitor |
| 03/05/2008 | CN100372871C Promoter to IL-18BP, its preparation and use |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372846C Sulfonamido substituted imidazopyridines |
| 03/05/2008 | CN100372567C Thrombin derived peptides for promoting cardiac tissue repair |
| 03/05/2008 | CN100372535C Use of 4-pyridylmethyl-phthalazine derivatives for the manufacture of a medicament for the treatment of myelodysplastic syndromes |
| 03/05/2008 | CN100372534C Torasemide freeze-drying preparation and prepration method |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338963 blood coagulation factor (trypsin-like serine protease enzymes) inhibitor; 3-(4-methoxy-phenyl)-5-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-3,5,6,7-tetrahydro-[1,2,3]triazolo4,5-c]pyridin-4-one; anticoagulant; cardiovascular thromboembolic disorder transient ischemic attack, stroke, atherosclerosis |
| 03/04/2008 | US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists |
| 03/04/2008 | CA2329210C Process for preparation of enantiomerically pure n-methyl-n-[(1s)-1-phenyl-2((3s)-3-hydroxypyrrolidin-1-yl) ethyl]-2,2-diphenylacetamide |
| 02/28/2008 | WO2008024277A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/28/2008 | WO2008023235A1 Pyrazole derivatives as anti-platelet and anti-thrombotic agents |
| 02/28/2008 | WO2008023052A1 Combination of a fvii and a thrombin-activable factor x |
| 02/28/2008 | WO2008022786A1 Aminoacyl prodrug derivatives and medicaments for treatment of thromboembolic disorders |
| 02/28/2008 | WO2008006979A3 Process for preparing diaminophenothiazinium compounds |
| 02/28/2008 | WO2007146900A3 Antihypertensive therapy method |
| 02/28/2008 | WO2007120730A3 Fused ring thrombin receptor antagonists |
| 02/28/2008 | WO2007016095A3 Cyclooxygenase-2 selective inhibitor compounds comprising nitric oxide enhancing groups, compositions and methods of use |
| 02/28/2008 | US20080051436 Use of Acylaminothiazole Derivatives as Therapeutic Agents |
| 02/28/2008 | US20080051400 Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051388 Novel Compounds That Inhibit Factor Xa Activity |
| 02/28/2008 | US20080051356 Truncated 24kDa basic fibroblast growth factor |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051332 Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| 02/28/2008 | US20080051324 Medium-Chain Length Fatty Alcohols as Stimulators of Hematopoiesis |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080050429 Low flush niacin formulation |
| 02/28/2008 | US20080050391 Method for Treating Autoimmune Diseases With Antibodies |
| 02/28/2008 | US20080050389 Compositions and methods for prevention and treatment of uncontrolled formation of intravascular fibrin clots |
| 02/28/2008 | US20080050386 Novel proteins, gene encoding the same and method of utilization thereof |
| 02/28/2008 | US20080050371 Comprises immunoglobulin for treating and preventing inflammation, thrombocytopenia and/or autoimmune hemolytic anemia |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | US20080050310 Antibodies and immunoconjugates and uses therefor |
| 02/28/2008 | US20080050275 Manual processing systems and methods for providing blood components conditioned for pathogen inactivation |
| 02/28/2008 | CA2661044A1 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892297A2 Identification and molecular characterisation of proteins, expressed in the tick salivary glands |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1891999A1 Blood purifier |
| 02/27/2008 | EP1891044A1 Crystalline forms of a known pyrrolidine factor xa inhibitor |
| 02/27/2008 | EP1890686A1 Peritoneal dialysis fluid |
| 02/27/2008 | EP1506192B1 Substituted pyrroline kinase inhibitors |
| 02/27/2008 | EP1496873B1 Chewable soft capsule |
| 02/27/2008 | EP1039906B1 metal complexes with antibacterian and fungicidal effects |
| 02/27/2008 | CN101132788A Diosmetin derivative for treating and preventing disease of thrombosis |
| 02/27/2008 | CN101130049A Traditional Chinese medicine for treating epigastric pain gastrorrhagia |
| 02/27/2008 | CN101130040A Oral liquid of Baiye Jiesui |
| 02/27/2008 | CN101130039A Biochemistry oral liquid of shenling |
| 02/27/2008 | CN101130032A Proprietary Chinese medicine for building up body, qi-benefitting and blood-nourishing after miscarriage or dilatation curettage |
| 02/27/2008 | CN101130021A Liquid for bleeding air and backing blood |
| 02/27/2008 | CN101129972A Traditional Chinese medicine composition, preparation method and use of the same |
| 02/27/2008 | CN101129958A Traditional Chinese medicine for treating cataptosis |
| 02/27/2008 | CN101129950A Orally taken traditional Chinese medicine composition for treating diabetes insipidus |
| 02/27/2008 | CN101129943A Traditional Chinese medicine for treating cirrhosis after hepatitis |
| 02/27/2008 | CN101129850A Traditional Chinese medicine preparation for treating hemafecia |
| 02/27/2008 | CN101129794A Traditional Chinese medicine for treating bronchiolectasis hemoptysis |
| 02/27/2008 | CN101129740A Drink of glutinous rehmannia for cooling blood |
| 02/27/2008 | CN101129729A Powder of fennel for spleen |
| 02/27/2008 | CN101129682A Traditional Chinese medicine for treating late ascites of liver cancer |
| 02/27/2008 | CN101129615A Oral liquid of caulis spatho lobi |
| 02/27/2008 | CN101129587A Traditional Chinese medicine composition for treating hemafecia |
| 02/27/2008 | CN101129576A Bolus of eight delicacies with motherwort |
| 02/27/2008 | CN101129520A Chinese medicinal herb formula for treating thrombocytopenia |
| 02/27/2008 | CN101129469A Traditional Chinese medicine composition for preventing and controlling cardiovascular disease |
| 02/27/2008 | CN101129406A Formula of compound colla carapaeis corii asini series products and method for producing the same |
| 02/27/2008 | CN101129349A Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 02/27/2008 | CN101129145A Countenance preserving cake and technique for producing the same |
| 02/27/2008 | CN100371011C Chinese medicine fast-acting ointment for treating septicemia |
| 02/27/2008 | CN100370976C Medicine containing shikonin compound as active component |
| 02/27/2008 | CN100370967C Implantable gel compositions and preparing method of thereof |
| 02/26/2008 | US7335773 induce the biosynthesis of cytokines such as interferon and tumor necrosis factor; exhibit antiviral and antitumor properties |
| 02/26/2008 | US7335680 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 02/26/2008 | US7335649 3-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-2-hydroxy-3'-(tetrazol-5-yl)biphenyl for treatment of thrombocytopenia; colony stimulating factors |
| 02/26/2008 | US7335634 Von Willebrand Factor (VWF); prevents a bleeding diathesis and reduces pre-, peri- and postoperative blood loss in acquired Von Willebrand syndromes such as in cardiovascular diseases requiring surgical procedures |
| 02/26/2008 | CA2230159C Use of aminoadamantane compounds as immunoregulators |
| 02/21/2008 | WO2008021796A2 Pyrrolidinone anilines as progesterone receptor modulators |
| 02/21/2008 | WO2008021283A2 Compositions and methods for increasing blood platelet levels in humans |
| 02/21/2008 | WO2008021124A2 Compositions and drug-delivery systems comprising rapamycin analogs and paclitaxel |
| 02/21/2008 | WO2008020622A1 NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND |
| 02/21/2008 | WO2008020532A1 Novel crystal of 5-aminolevulinic acid phosphate and process for production thereof |
| 02/21/2008 | WO2007124308A3 Methods and compositions for modulation of blood-neural barrier |
| 02/21/2008 | WO2007075809A3 Oxazoloisoquinoline derivatives as thrombin receptor antagonists |
| 02/21/2008 | WO2007042010A3 Synergistic pharmaceutical composition containing a peptide with 2 to 5 amino acids |
| 02/21/2008 | US20080045555 hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors; avoiding adverse effects such as hepatotoxicity and cutaneous flushing; low dosage; 2-bromo-8-methyl-4-pentyl-1,4-dihydro-5H-[1,2,4]triazolo[5,1-i]purin-5-one; to treat cardiovascular disorders |
| 02/21/2008 | US20080045551 Pharmaceutical combination comprising an adenosine a1 antagonist and a radiocontrast media |
| 02/21/2008 | US20080045540 Sulfonyl pyrrolidines, method for producing the same and their use as drugs |
| 02/21/2008 | US20080045524 Selective NPY (Y5) antagonists |